JPRN-C000000135CompletedPhase 2
A combination phase II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer. - A combination phase II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer.
Institute of Biomedical Research and Innovation0 sites40 target enrollmentStarted: September 8, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 70years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)After thoracic irradiation 2)A case having severe infection and a serious complication 3)Requiring treatment pleural/ascites /pericardial effusion, 4)Interstitial pneumonia or active lung fibrosis on chest X-ray, 5)Symptomatic brain metastases 6)Double cancer 7)Others
Investigators
Similar Trials
Completed
Not Applicable
Phase 2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerung squamous cell carcinomaJPRN-UMIN000004833First Department of Surgery, Hamamatsu University School of Medicine25
Unknown
Phase 1
Phase 1/2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerPreaviously untreated advanced advanced squamous cell lung cancerJPRN-C000000439Department of Respiratory Medicine of Kyoto University Hospital32
Completed
Not Applicable
A combination phase I/II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancerpreviously untreated elderly non-small cell lung cancerJPRN-C000000072West Japan Oncology Group25
Completed
Phase 1
PhaseI study of the combination of gemcitabine, cisplatin and S-1 in advanced biliary tract canceradvanced biliary tract cancerJPRN-UMIN000006548ational Cancer Center Hospital24
Active, not recruiting
Not Applicable
A Phase 2 Single-Arm study of gemcitabine in combination with Oxaliplatin in Pediatric patients with relapsed or refractory neuroblastoma or miscellaneous solid non-CNS tumors - NDEUCTR2005-005219-36-ITELI LILLY49